Immediate Impact
1 by Nobel laureates 1 from Science/Nature 50 standout
Citing Papers
Bacterial siderophores: diversity, uptake pathways and applications
2024 Standout
Ironing out the details of ferroptosis
2024 Standout
Works of Herbert Opitz being referenced
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Herbert Opitz | 234 | 230 | 64 | 6 | 269 | |
| C Ciaccio | 226 | 178 | 62 | 8 | 332 | |
| Helen Berdousi | 263 | 237 | 58 | 10 | 299 | |
| Roberto Malizia | 268 | 247 | 52 | 5 | 295 | |
| MJ Pippard | 264 | 251 | 64 | 8 | 330 | |
| P. D. Jensen | 208 | 210 | 33 | 7 | 265 | |
| Anne Nørd | 302 | 294 | 54 | 6 | 328 | |
| John Feigert | 165 | 186 | 17 | 7 | 238 | |
| Peter Klug | 295 | 254 | 121 | 7 | 330 | |
| Francesco Gagliardotto | 146 | 119 | 24 | 10 | 198 | |
| D. Gailani | 164 | 228 | 15 | 6 | 297 |
All Works
Loading papers...